Table 2 Baseline Socio-demographic and clinical characteristics in the CAPRISA 002 trials
Variables | Count/Mean (Percentage/SD) |
|---|---|
Marital Status, n(%) | |
 Single/no partner | 34(15.5) |
 Married/stable partner | 174 (79.5) |
 Many partners | 11 (5.0) |
Educational Status, n(%) | |
  ≤ Grade 8 | 16 (7.31) |
 Grade 9–10 | 50 (22.8) |
  ≥ Grade 11 | 153 (69.9) |
Age Categories, n(%) | |
 18–20 years | 29 (13.2) |
 21–39 years | 178 (81.3) |
 40–59 years | 12 (5.5) |
BMI Categories, n(%) | |
 Underweight | 5 (2.3) |
 Healthy weight | 76 (34.9) |
 Overweight/Obese | 137 (62.8) |
Baseline immunologic state, n(%) | |
  < 200 CD4 cells/mm3 | 9 (4.1) |
 200–349 CD4 cells/mm3 | 41 (18.7) |
 350–499 CD4 cells/mm3 | 89 (40.6) |
  ≥ 500 CD4 cells/mm3 | 80 (36.5) |
Contraceptive use, n(%) | |
 No | 40 (18.3) |
 Yes | 179 (81.7) |
Anaemia, n(%) | |
 No | 208 (95.0) |
 Yes | 11 (5.0) |
TB Co-infection, n(%) | |
 No | 201 (91.8) |
 Yes | 18 (9.2) |
Sex acts under the influence of alcohol, n(%) | |
 No | 197 (90.0) |
 Yes | 22 (10.0) |
Viral load log10copies/ml, Mean (SD) | 4.46 (0.85) |
Number of transitions between stage, n(%) | |
 Transition 1: Normal to Mild | 447 (26.1) |
 Transition 2: Mild to Advance | 374 (21.9) |
 Transition 3: Advanced to Severe | 103 (6.03) |
 Transition 4: Severe to Advance | 83 (4.9) |
 Transition 5: Advance to Mild | 318 (18.9) |
 Transition 6: Mild to Normal | 386 (22.6) |